| P50 | author | Sinee Disthabanchong | Q51553252 |
| P2093 | author name string | E A González | |
| P2860 | cites work | Novel regulators of bone formation: molecular clones and activities | Q24297338 |
| | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis | Q24324701 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 |
| | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 |
| | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 |
| | The family of bone morphogenetic proteins | Q28145930 |
| | Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone | Q28241025 |
| | Bone: formation by autoinduction | Q28251545 |
| | RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis | Q28293009 |
| | TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | Murine osteogenic protein (OP-1): High levels of mRNA in kidney | Q33265993 |
| | Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice | Q33632889 |
| | Purification and characterization of other distinct bone-inducing factors | Q33684861 |
| | Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins | Q33697455 |
| | The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. | Q33823576 |
| | Regulation of Smad activity | Q33830190 |
| | Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction | Q33886695 |
| | The role of cytokines in skeletal remodelling: possible consequences for renal osteodystrophy | Q33947732 |
| | Osteoclastic bone resorption by a polarized vacuolar proton pump | Q34441726 |
| | Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone | Q35595884 |
| | Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone | Q35752203 |
| | Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption | Q36290634 |
| | RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 |
| | Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin | Q39116155 |
| | Mechanism of bone turnover | Q40769931 |
| | Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells | Q40927574 |
| | STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroi | Q40945774 |
| | Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). | Q40956363 |
| | Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells | Q41331286 |
| | Identification of osteoclast-specific monoclonal antibodies | Q41488082 |
| | Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha | Q44532107 |
| | Bone histology in incipient and advanced renal failure | Q44735570 |
| | Effects of inhibitors of signal transduction pathways on transforming growth factor beta1 and osteogenic protein-1-induced insulinlike growth factor binding protein-3 expression in human bone cells | Q46229992 |
| | Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. | Q51005281 |
| | Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms. | Q52190075 |
| | Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. | Q54159612 |
| | Plasma insulin-like growth factors and bone formation in uremic hyperparathyroidism | Q57691602 |
| P433 | issue | 3 | |
| P304 | page(s) | 240-249 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Journal of Investigative Medicine | Q15759787 |
| P1476 | title | Regulation of bone cell development and function: implication for renal osteodystrophy | |
| P478 | volume | 49 | |